Johanna Schleutker
Researcher Next ID · RN-025022
Researcher · Medicine
Turku, Finland
- Works count
- 364
- Citation count
- 27,573
- H-index
- 64
- i10-index
- 198
Research interests
Publications
Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants
Nature Genetics · 2023 · https://doi.org/10.1038/s41588-023-01534-4
Genetic Risk Factors Associated With Preeclampsia and Hypertensive Disorders of Pregnancy
JAMA Cardiology · 2023 · https://doi.org/10.1001/jamacardio.2023.1312
Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction
Nature Genetics · 2021 · https://doi.org/10.1038/s41588-020-00748-0
Inherited myeloproliferative neoplasm risk affects haematopoietic stem cells
Nature · 2020 · https://doi.org/10.1038/s41586-020-2786-7
An integrative multi-omics analysis to identify candidate DNA methylation biomarkers related to prostate cancer risk
Nature Communications · 2020 · https://doi.org/10.1038/s41467-020-17673-9
Association analyses identify 31 new risk loci for colorectal cancer susceptibility
Nature Communications · 2019 · https://doi.org/10.1038/s41467-019-09775-w
Genetic architecture of human plasma lipidome and its link to cardiovascular disease
Nature Communications · 2019 · https://doi.org/10.1038/s41467-019-11954-8
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
Nature Genetics · 2018 · https://doi.org/10.1038/s41588-018-0142-8
Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts
BMJ · 2018 · https://doi.org/10.1136/bmj.j5757
Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types
Cancer Discovery · 2016 · https://doi.org/10.1158/2159-8290.cd-15-1227
RAD51B in Familial Breast Cancer
PLoS ONE · 2016 · https://doi.org/10.1371/journal.pone.0153788
REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants
The American Journal of Human Genetics · 2016 · https://doi.org/10.1016/j.ajhg.2016.08.016
A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer
Nature Genetics · 2014 · https://doi.org/10.1038/ng.3094
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array
Nature Genetics · 2013 · https://doi.org/10.1038/ng.2560
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study
Nature Genetics · 2011 · https://doi.org/10.1038/ng.882
Identification of seven new prostate cancer susceptibility loci through a genome-wide association study
Nature Genetics · 2009 · https://doi.org/10.1038/ng.450
Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility
Nature Genetics · 2009 · https://doi.org/10.1038/ng.448
A recurrent mutation in PALB2 in Finnish cancer families
Nature · 2007 · https://doi.org/10.1038/nature05609
Germline Alterations of the RNASEL Gene, a Candidate HPC1 Gene at 1q25, in Patients and Families with Prostate Cancer
The American Journal of Human Genetics · 2002 · https://doi.org/10.1086/340450
Germline mutations in the ribonuclease L gene in families showing linkage with HPC1
Nature Genetics · 2002 · https://doi.org/10.1038/ng823
Evidence for a prostate cancer susceptibility locus on the X chromosome.
Nature Genetics · 1998 · https://doi.org/10.1038/2477
Current projects
No projects listed.